Cardiology

China Gene Edited Babies
Exclusive

‘CRISPR babies’ lab asked U.S. scientist for help to disable cholesterol gene in human embryos

By Sharon Begley

Arena Pharmaceuticals
Biotech

United Therapeutics licenses Arena hypertension drug in a deal worth up to $1.2 billion

By Kate Sheridan

MORE Red Blood Cells
In the Lab

Generic arthritis drug comes up short against inflammation in heart disease

By Elizabeth Cooney

Electrocardiogram readout
Health

Low income explains poorer survival after a heart attack more than race, study finds

By Elizabeth Cooney

echocardiogram
In the Lab

Heart failure study paused over concerns about disputed cell therapy papers

By Elizabeth Cooney

Anatomical heart
Biotech

A new drug lowers cholesterol. Can it spoil a multibillion-dollar market?

By Damian Garde

Cholesterol Drugs
Pharmalot

Amgen lowers wholesale price for its cholesterol medicine in bid to remain competitive

By Ed Silverman

Health

The EKG is only a start. Apple wants to seize the market for patient monitoring

By Casey Ross

New England Journal of Medicine
Health

New England Journal pulls one paper, probes two others from stem cell researcher

By Elizabeth Cooney

Brigham and Women's
Exclusive

Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research

By Ivan Oransky and Adam Marcus

The Readout LOUD

LISTEN: A fish oil epiphany, VC monopolies, and ketamine clinics

By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Video

WATCH: New blood vessels, straight from the printer

By Hyacinth Empinado and Dominic Smith

Apple Showcase Electrocardiogram
First Opinion

The next Apple Watch wants to monitor your heart. Should you let it?

By Anthony Pearson

New apple watch
Health

The new Apple Watch, with FDA’s blessing, comes with an EKG app

By Kate Sheridan

Yoko K. Sen
Health

Anatomy of a beep: A medical device giant and an avant-garde musician set out to redesign a heart monitor’s chirps

By Eric Boodman

Racial bias Pain Management
Pharmalot

FDA widening probe into heart drugs linked to cancer risk

By Ed Silverman

Fish oil capsule
Biotech

Negative fish oil study results raise the stakes for Amarin’s capsule

By Adam Feuerstein

A woman undergoing a cardiological examination.
Health

Women survive a heart attack more often when their doctor is female, study finds

By Orly Nadell Farber

Amarin Transcript
Biotech

Archived chat: Breaking down Amarin’s highly anticipated REDUCE-IT trial

By Adam Feuerstein

Anatomical heart
In the Lab

Bayer teams up with the Broad to tackle congestive heart failure

By Jonathan Saltzman — Boston Globe

Rolle Blood Vessel 02
In the Lab

‘Living Legos’ form blood vessels to simulate heart disease and test drugs

By Elizabeth Cooney

Exclusive

Alcohol study failed to seek FDA approval, possibly violating federal rules

By Sharon Begley

Cardio Exam
Health

After malpractice caps, doctors ordered fewer invasive tests to diagnose heart attacks

By Elizabeth Cooney

Risk Calculator
Health

New risk calculator could change the aspirin, statins, and blood pressure medications some people take

By Elizabeth Cooney

Cholesterol
Biotech

A tiny biotech’s plot to frustrate Regeneron and Sanofi runs into a safety problem

By Damian Garde

Express Scripts flag
Biotech

Saddled with sluggish sales, Regeneron and Sanofi slash the cost of cholesterol-lowering drug

By Damian Garde

Victor Gurewich
In the Lab

At 88, this doctor won’t give up on a long-ignored treatment for strokes and heart attacks

By Karen Weintraub

STAT MADNESS
In the Lab

Rebuilding dying hearts: Meet the STAT Madness 2018 crowd favorite

By Elizabeth Cooney

Financial Meltdown Unemployment
Health

Another fallout from the Great Recession: Fewer people took their blood pressure and diabetes medications

By Kate Sheridan

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy